Document is current
Any future updates will be listed below
-
Authors
Diamantidis, Clarissa J.
Hale, Sarah L.
Wang, Virginia
Smith, Valerie A.
Scholle, Sarah Hudson
Maciejewski, Matthew L. https://orcid.org/0000-0003-1765-5938
-
Funding
Funding for this research was provided by:
Centers for Medicare and Medicaid Services (HHSM-500-2014-00442G)
Health Services Research and Development (RCS 10-391, CIN 14-310)
- License Information
-
More Information
Article History
Received: 26 June 2019
Accepted: 6 September 2019
First Online: 14 September 2019
Ethics approval and consent to participate
: This study was approved by the Duke Institutional Review Board Pro00057801.The Duke IRB ruled that informed consent did not apply to this study.
: Not applicable.
: The coauthors reported receiving institutional grants from the Department of Veterans Affairs HSR&D (MLM, VW, VS), the National Institute for Drug Abuse (MLM, VS) the National Institute of Diabetes and Digestive and Kidney Diseases (CJD, MLM, VW), the National Cancer Institute (MLM), and an institutional contract from the Centers for Medicare and Medicaid Services (CJD, MLM, SLH, VW, SHS, VS). MLM reports ownership of Amgen stock. VW is an editorial board member at BMC Nephrology.
